youd think saving toes feet and legs from amputation and saving a patient amputee from mortality likely infection
would raise more than eyebrows
i reckon post cap raise once funded again this share willsoar back to levels see in 2021
ie 300 m ill mcap not an unrealistic valuation by start phase 11/111 i am pretty sure
Ann: Additional Positive Patient Cases - Special Access Scheme, page-7
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $112.1M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 55.0¢ | 55.0¢ | $2.013K | 3.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 40270 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 171533 | 3 |
View Market Depth
| Last trade - 10.06am 17/06/2024 (20 minute delay) ? |
| RCE (ASX) Chart |